Point-counterpoint: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; Two promising combinations - No definite conclusions

International Journal of Hyperthermia

Volumn 18, Issue 1, 2002, Pages 19-24

  Van Der Zee, J ^a   Koper, P C M ^a   Lutgens, L C H W ^a   Burger, C W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Cisplatin; Hyperthermia; Radiotherapy; Therapeutic ratio

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPERTHERMIC THERAPY; MEDICAL ETHICS; OUTCOMES RESEARCH; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS; UTERINE CERVICAL NEOPLASMS;

EID: 0036148231     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730110083738     Document Type: Review

References (22)

1. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer
2. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer
3. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
4. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study
5. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
6. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial
7. Literature analysis of hig dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?
8. Thermoradiotherapy in the management of carcinoma cervix (stage IIIb): A controlled clinical study
9. A prospective randomised study of local hyperthermia as a supplement and radiosensitiser in the treatment of carcinoma of the cervix with radiotherapy
10. A randomised clinical trial of radiation therapy versus thermoradiotherapy in stage IIIb cervical carcinoma
11. Review. Chemoradiation for carcinoma of the cervix: Advances and opportunities
12. A clinical trial comparing concurrent cisplatin and radiation therapy versus radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group
13. The adverse effect of treatment prolongation in cervical carcinoma
14. The importance of hemoglobin levels during radiotherapy of the cervix
15. Editorial. Improved treatment for cervical cancer - Concurrent chemotherapy and radiotherapy
16. Early and late damage in the mouse bladder after radiation combined with cyclophosphamide or cisplatinum, evaluated by two different functional assays
17. Randomized trial hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer
18. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
19. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes
20. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiological aspects. A review
21. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE)
22. Therapeutic gain by hyperthermia added to radiotherapy